Flagship Pioneering’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,170,059
| Closed | -$12.2M | – | 8 |
|
|
2023
Q3 | $12.2M | Sell |
1,170,059
-3
| -0% | -$24 | 0.89% | 8 |
|
|
2023
Q2 | $6.39M | Hold |
1,170,062
| – | – | 0.29% | 9 |
|
|
2023
Q1 | $14M | Hold |
1,170,062
| – | – | 0.55% | 7 |
|
|
2022
Q4 | $9.36M | Buy |
1,170,062
+415,351
| +55% | +$10.8M | 0.3% | 8 |
|
|
2022
Q3 | $32.3M | Hold |
754,711
| – | – | 1.36% | 8 |
|
|
2022
Q2 | $38.3M | Hold |
754,711
| – | – | 1.44% | 8 |
|
|
2022
Q1 | $48.5M | Buy |
754,711
+252,774
| +50% | +$12.6M | 1.14% | 9 |
|
|
2021
Q4 | $26.2M | Hold |
501,937
| – | – | 0.41% | 12 |
|
|
2021
Q3 | $37.4M | Hold |
501,937
| – | – | 0.39% | 12 |
|
|
2021
Q2 | $50.3M | Hold |
501,937
| – | – | 0.64% | 10 |
|
|
2021
Q1 | $59.7M | Hold |
501,937
| – | – | 0.96% | 10 |
|
|
2020
Q4 | $65.1M | Hold |
501,937
| – | – | 1.19% | 10 |
|
|
2020
Q3 | $58M | Hold |
501,937
| – | – | 1.6% | 7 |
|
|
2020
Q2 | $69.4M | Buy |
501,937
+152,000
| +43% | +$18.6M | 2.02% | 7 |
|
|
2020
Q1 | $29.9M | Hold |
349,937
| – | – | 1.4% | 7 |
|
|
2019
Q4 | $35.1M | Hold |
349,937
| – | – | 1.96% | 7 |
|
|
2019
Q3 | $49.5M | Hold |
349,937
| – | – | 2.71% | 8 |
|
|
2019
Q2 | $81.4M | Buy |
+349,937
| New | +$111M | 3.53% | 6 |
|
Other funds holding AXLA
Flagship Pioneering's AXLA Position: Q4 2023 in Review
Flagship Pioneering sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 1,170,059 shares — an estimated $12.2M sold.
Flagship Pioneering first reported a position in AXLA in Q2 2019 and held it in 18 quarters. The position peaked at $81.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- Flagship Pioneering reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Flagship Pioneering sold 1,170,059 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $12.2M.
- Flagship Pioneering first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- Flagship Pioneering's Axcella Health Inc. Common Stock position peaked at $81.4M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on Flagship Pioneering's 13F filing for Q4 2023, filed 14 Feb 2024.